In addition, at the age of 4.5 months APP-SAA mice likely do not have CAA-like amyloid deposits, therefore this paradigm might not be suitable for the detection of chronic anti-Aβ antibody treatment effect on microbleeds. The gene discussed is APP; the disease is amyloidosis.